Pages that link to "Q37739881"
Jump to navigation
Jump to search
The following pages link to Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition (Q37739881):
Displaying 50 items.
- Tau PET imaging: present and future directions (Q34680852) (← links)
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case (Q42672461) (← links)
- The emerging role of PET imaging in dementia. (Q42701971) (← links)
- Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies. (Q46240783) (← links)
- Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease (Q46682283) (← links)
- Amyloid Associated Intermittent Network Disruptions in Cognitively Intact Older Subjects: Structural Connectivity Matters (Q47194750) (← links)
- Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia (Q47330246) (← links)
- [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging (Q47694602) (← links)
- Ambulatory pulse pressure, brain neuronal fiber integrity, and cerebral blood flow in older adults (Q47926690) (← links)
- Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. (Q47985518) (← links)
- The association between tau PET and retrospective cortical thinning in clinically normal elderly (Q49322919) (← links)
- Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions (Q49957645) (← links)
- Tau Positron Emission Tomography in Autosomal Dominant Alzheimer Disease: Small Windows, Big Picture (Q50051789) (← links)
- MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([(18)F]-AV-1451) Binding. (Q50061690) (← links)
- Biomarker-based diagnostics of Alzheimer's disease : Concept of suspected non-Alzheimer pathology (Q50103609) (← links)
- Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake (Q50531762) (← links)
- Longitudinal tau PET in ageing and Alzheimer's disease (Q51763159) (← links)
- Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease. (Q51766183) (← links)
- Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? (Q52315334) (← links)
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. (Q52589491) (← links)
- Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias. (Q55254017) (← links)
- Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants. (Q55311648) (← links)
- Topographic staging of tau positron emission tomography images. (Q55463444) (← links)
- The development and validation of tau PET tracers: current status and future directions (Q56863907) (← links)
- Comparison of longitudinal Aβ in nondemented elderly and Down syndrome (Q57821182) (← links)
- A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease (Q57927766) (← links)
- In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease (Q58693324) (← links)
- A novel partial volume correction method for accurate quantification of [F] flortaucipir in the hippocampus (Q58778649) (← links)
- Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression (Q59329082) (← links)
- Imaging and Molecular Mechanisms of Alzheimer's Disease: A Review (Q60950130) (← links)
- Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia (Q61452943) (← links)
- The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? (Q63101708) (← links)
- Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease (Q64060660) (← links)
- Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain (Q64071535) (← links)
- Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue (Q64106160) (← links)
- A walk through tau therapeutic strategies (Q64245708) (← links)
- Clinical Imaging of Choroid Plexus in Health and in Brain Disorders: A Mini-Review (Q64252972) (← links)
- Biomarkers for tau pathology. (Q64952063) (← links)
- Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain. (Q64965222) (← links)
- Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo. (Q64982207) (← links)
- FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis (Q88053895) (← links)
- Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials? (Q88492625) (← links)
- Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects (Q88574025) (← links)
- The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials (Q89217982) (← links)
- Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity (Q89751795) (← links)
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration (Q89984108) (← links)
- The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes (Q95006715) (← links)
- Tau pathology in cognitively normal older adults (Q90089071) (← links)
- Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment (Q90104103) (← links)
- A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia (Q90140035) (← links)